Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marvin M van Luijn

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|May 28, 2020
B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential TriggersJamie van Langelaar, Liza Rijvers, Joost Smolders, et al.
Seminars in Immunopathology|April 2, 2022
T-cell surveillance of the human brain in health and multiple sclerosisJoost Smolders, Marvin M van Luijn, Cheng-Chih Hsiao, et al.
Immunology Letters|July 14, 2023
Epstein-Barr virus and genetic risk variants as determinants of T-bet<sup>+</sup> B cell-driven autoimmune diseasesLaurens Bogers, Kirsten L Kuiper, Joost Smolders, et al.
Journal of Autoimmunity|February 3, 2026
What's in a name? - juxtaposing T follicular, peripheral and resident helper cells in B cell-driven autoimmune diseasesFabiënne van Puijfelik, Kirsten L Kuiper, Jasper Rip, et al.
Oncoimmunology|May 13, 2015
Class II-associated invariant chain peptide as predictive immune marker in minimal residual disease in acute myeloid leukemiaMarvin M van Luijn, Willemijn van den Ancker, S Marieke van Ham, et al.
Scientific Reports|September 26, 2025
Antinuclear antibodies in early multiple sclerosis reflect systemic lupus erythematosus shared risk factorsCato E A Corsten, Ana M Marques, Despoina Masmanidou, et al.
Oncoimmunology|June 22, 2012
Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentationMarvin M van Luijn, Martine E D Chamuleau, Gert J Ossenkoppele, et al.
Journal of Neuroimmunology|July 19, 2021
Proportions of circulating transitional B cells associate with MRI activity in interferon beta-treated multiple sclerosis patientsMax Mimpen, Jan Damoiseaux, William van Doorn, et al.
Med (New York, N.Y.)|March 26, 2024
Twin study dissects CXCR3<sup>+</sup> memory B cells as non-heritable feature in multiple sclerosisFlorian Ingelfinger, Kirsten L Kuiper, Can Ulutekin, et al.
The American Journal of Pathology|September 13, 2011
Class II-associated invariant chain peptide expression represents a novel parameter for flow cytometric detection of acute promyelocytic leukemiaMarvin M van Luijn, Theresia M Westers, Martine E D Chamuleau, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|May 28, 2020
B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential TriggersJamie van Langelaar, Liza Rijvers, Joost Smolders, et al.
Seminars in Immunopathology|April 2, 2022
T-cell surveillance of the human brain in health and multiple sclerosisJoost Smolders, Marvin M van Luijn, Cheng-Chih Hsiao, et al.
Immunology Letters|July 14, 2023
Epstein-Barr virus and genetic risk variants as determinants of T-bet<sup>+</sup> B cell-driven autoimmune diseasesLaurens Bogers, Kirsten L Kuiper, Joost Smolders, et al.
Journal of Autoimmunity|February 3, 2026
What's in a name? - juxtaposing T follicular, peripheral and resident helper cells in B cell-driven autoimmune diseasesFabiënne van Puijfelik, Kirsten L Kuiper, Jasper Rip, et al.
Oncoimmunology|May 13, 2015
Class II-associated invariant chain peptide as predictive immune marker in minimal residual disease in acute myeloid leukemiaMarvin M van Luijn, Willemijn van den Ancker, S Marieke van Ham, et al.
Scientific Reports|September 26, 2025
Antinuclear antibodies in early multiple sclerosis reflect systemic lupus erythematosus shared risk factorsCato E A Corsten, Ana M Marques, Despoina Masmanidou, et al.
Oncoimmunology|June 22, 2012
Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentationMarvin M van Luijn, Martine E D Chamuleau, Gert J Ossenkoppele, et al.
Journal of Neuroimmunology|July 19, 2021
Proportions of circulating transitional B cells associate with MRI activity in interferon beta-treated multiple sclerosis patientsMax Mimpen, Jan Damoiseaux, William van Doorn, et al.
Med (New York, N.Y.)|March 26, 2024
Twin study dissects CXCR3<sup>+</sup> memory B cells as non-heritable feature in multiple sclerosisFlorian Ingelfinger, Kirsten L Kuiper, Can Ulutekin, et al.
The American Journal of Pathology|September 13, 2011
Class II-associated invariant chain peptide expression represents a novel parameter for flow cytometric detection of acute promyelocytic leukemiaMarvin M van Luijn, Theresia M Westers, Martine E D Chamuleau, et al.
Pageof 5